Skip to content

Application of alfentanil combined with propofol in oocyte retrieval

Application of alfentanil combined with propofol in oocyte retrieval

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099533
Enrollment
Unknown
Registered
2025-03-25
Start date
2024-11-13
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Experimental group (AF group):Intravenous alfentanil hydrochloride 8µg/kg
Control group (Group F):Intravenous fentanyl 1.2µg/kg

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. ASA grade I.~II., BMI of 18~28 kg/m, operation time <= 15 minutes. 2. Be aware and be able to communicate with doctors. Able to understand the visual analogue scale under the guidance of a physician(Visual Analogue Scale,VAS); 3. Patients with normal preoperative routine ECG and liver and kidney function; 4. No history of cardiovascular diseases such as hypertension and coronary heart disease in the past; 5. No serious hematologic diseases; 6. No recent upper respiratory tract infection.

Exclusion criteria

Exclusion criteria: 1. Long-term history of use of narcotic analgesics, sedatives or non-steroidal anti-inflammatory drugs; 2. History of neurological and psychiatric diseases before surgery; 3. Patients with a history of habitual reflux vomiting.

Design outcomes

Primary

MeasureTime frame
Apnea;Diaphragmatic excursion;

Secondary

MeasureTime frame
Body mass index;Age;American Society of Anesthesiologists Physical Status Classification;Number of egg retrieval cycles;The number of follicles >= 14 mm was monitored;Propofol induction dose;Number of propofol additions;Total propofol dosage;Propofol effector chamber concentration;Duration of surgery;Wake up time;Heart rate;Mean arterial pressure;Respiratory rate;Oxygen saturation;End-tidal carbon dioxide;Perioperative adverse events (hypoxemia, respiratory depression, hypotension, bradycardia, nausea and vomiting, vertigo, blurred vision);Modified Observer"s Assessment of Alertness/Sedation;Visual Analogue Scale;Number of eggs retrieved;Patient comfort score;Surgeon satisfaction score;

Countries

China

Contacts

Public ContactGuangying Zhang

The First Affiliated Hospital of Guangxi Medical University

86799488@qq.com+86 150 7717 6909

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026